Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans
- PMID: 1601035
- DOI: 10.1002/eji.1830220617
Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans
Abstract
We have examined the regulation of complement dependent phagocytosis by macrophage-activating cytokines. Tumor necrosis factor (TNF)-alpha and granulocyte-macrophage colony-stimulating factor (GM-CSF), but not interferon-gamma, interleukin-4 or macrophage-CSF, stimulated ingestion of the encapsulated fungal pathogen Cryptococcus neoformans by resident peritoneal macrophages in vitro. This was dependent upon opsonization of the yeasts with complement, 72 h of incubation with the cytokines for maximum effect, and the obligate involvement of the macrophage CR3 receptor. TNF-alpha and GM-CSF synergized at low concentrations, resulting in dramatic up-regulation of phagocytosis when compared to either cytokine alone. Supernatants from C. neoformans-specific T cells also increased macrophage phagocytic efficiency. Finally, the administration of neutralizing mAb specific for TNF-alpha and GM-CSF increased mortality in C. neoformans-infected mice, and induced the rapid progression of disease with involvement of the brain and meninges. We conclude that TNF-alpha and GM-CSF are potent regulators of complement-dependent phagocytosis by murine macrophages. Macrophage activation with these two cytokines can completely overcome the anti-phagocytic properties of the virulent yeasts. Our results, therefore, implicate TNF-alpha and GM-CSF as important mediators of resistance to encapsulated pathogens such as C. neoformans where ingestion of the organism is a critical process in host resistance.
Similar articles
-
CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.Immunology. 1997 Jun;91(2):289-96. doi: 10.1046/j.1365-2567.1997.00238.x. Immunology. 1997. PMID: 9227330 Free PMC article.
-
Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.J Immunol. 1994 Jan 15;152(2):724-34. J Immunol. 1994. PMID: 8283047
-
Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.J Immunol. 1989 Aug 15;143(4):1198-205. J Immunol. 1989. PMID: 2473121
-
Cytokines and costimulatory molecules: positive and negative regulation of the immune response to Cryptococcus neoformans.Arch Immunol Ther Exp (Warsz). 2000;48(6):465-72. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11197600 Review.
-
Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.FEMS Immunol Med Microbiol. 2012 Mar;64(2):147-61. doi: 10.1111/j.1574-695X.2011.00871.x. FEMS Immunol Med Microbiol. 2012. PMID: 22029633 Review.
Cited by
-
Associations between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: A Review.J Fungi (Basel). 2021 Mar 30;7(4):260. doi: 10.3390/jof7040260. J Fungi (Basel). 2021. PMID: 33808500 Free PMC article. Review.
-
Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.Am J Pathol. 2010 Feb;176(2):774-85. doi: 10.2353/ajpath.2010.090634. Epub 2010 Jan 7. Am J Pathol. 2010. PMID: 20056835 Free PMC article.
-
Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells.Infect Immun. 1996 Jun;64(6):2336-8. doi: 10.1128/iai.64.6.2336-2338.1996. Infect Immun. 1996. PMID: 8675346 Free PMC article.
-
GM-CSF: A Promising Target in Inflammation and Autoimmunity.Immunotargets Ther. 2020 Oct 29;9:225-240. doi: 10.2147/ITT.S262566. eCollection 2020. Immunotargets Ther. 2020. PMID: 33150139 Free PMC article. Review.
-
Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigens.Clin Vaccine Immunol. 2009 Aug;16(8):1213-21. doi: 10.1128/CVI.00100-09. Epub 2009 Jun 3. Clin Vaccine Immunol. 2009. PMID: 19494083 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources